Literature DB >> 23675562

Understanding basic steps to hematopoietic stem cell transplantation evaluation.

Melissa Logue1, Bipin N Savani.   

Abstract

We are celebrating one millionth transplant in year 2013! With continued improvement in hematopoietic cell transplantation (HCT) outcome, the indications for HCT continue to grow. Furthermore the sources of stem cells and the number of suitable matches are expanding. At the same time, modified transplantation regimens have facilitated safer procedures despite increase in patient's age and comorbidies. In the current era, any patient indicated for HCT has a stem cell source and therefore steps to HCT and coordinated pre-transplant care is an integral part of management to improve transplant outcome. This review discusses our approach to the transplant evaluation process and this article will serve as a valuable tool for primary care physicians and referring hematologists/oncologists.

Entities:  

Keywords:  Transplantation; evaluation; hematological malignancies; preparation

Year:  2013        PMID: 23675562      PMCID: PMC3649815     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  10 in total

1.  How can we improve life expectancy and quality of life in long-term survivors after allogeneic stem cell transplantation?

Authors:  Bipin N Savani
Journal:  Semin Hematol       Date:  2012-01       Impact factor: 3.851

2.  Transplantation in AML CR1.

Authors:  Bipin N Savani
Journal:  Blood       Date:  2010-09-16       Impact factor: 22.113

Review 3.  How we approach patient evaluation for hematopoietic stem cell transplantation.

Authors:  M Hamadani; M Craig; F T Awan; S M Devine
Journal:  Bone Marrow Transplant       Date:  2010-05-17       Impact factor: 5.483

Review 4.  Surviving the cure: long term followup of hematopoietic cell transplant recipients.

Authors:  N S Majhail; J Douglas Rizzo
Journal:  Bone Marrow Transplant       Date:  2013-01-07       Impact factor: 5.483

5.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Authors:  N S Majhail; J D Rizzo; S J Lee; M Aljurf; Y Atsuta; C Bonfim; L J Burns; N Chaudhri; S Davies; S Okamoto; A Seber; G Socie; J Szer; M T Van Lint; J R Wingard; A Tichelli
Journal:  Bone Marrow Transplant       Date:  2012-03       Impact factor: 5.483

6.  How I treat late effects in adults after allogeneic stem cell transplantation.

Authors:  Bipin N Savani; Michelle L Griffith; Shubhada Jagasia; Stephanie J Lee
Journal:  Blood       Date:  2010-12-30       Impact factor: 22.113

7.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

Review 8.  Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?

Authors:  S Nishiwaki; Y Atsuta; J Tanaka
Journal:  Bone Marrow Transplant       Date:  2013-03-11       Impact factor: 5.483

9.  Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.

Authors:  Issa F Khouri; Peter McLaughlin; Rima M Saliba; Chitra Hosing; Martin Korbling; Ming S Lee; L Jeffrey Medeiros; Luis Fayad; Felipe Samaniego; Amin Alousi; Paolo Anderlini; Daniel Couriel; Marcos de Lima; Sergio Giralt; Sattva S Neelapu; Naoto T Ueno; Barry I Samuels; Fredrick Hagemeister; Larry W Kwak; Richard E Champlin
Journal:  Blood       Date:  2008-04-14       Impact factor: 22.113

Review 10.  Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression.

Authors:  A Bacigalupo; J C W Marsh
Journal:  Bone Marrow Transplant       Date:  2012-11-26       Impact factor: 5.483

  10 in total
  1 in total

1.  The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation.

Authors:  Madeline L O'Sullivan; Rebecca A Shelby; Caroline S Dorfman; Sarah A Kelleher; Hannah M Fisher; Krista A Rowe Nichols; Francis J Keefe; Anthony D Sung; Tamara J Somers
Journal:  Support Care Cancer       Date:  2017-11-09       Impact factor: 3.359

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.